SCPhA Cruise on the Carnival Fantasy
Continuing Education Agenda
Sunday, September 16, 2012
8:00 AM - 10:00 AM
Making A Difference In Cardiovascular Diseas - Hypertension
Wayne Weart, Pharm.d, BCPS, FASHP
SC College of Pharm - MUSC Campus
Charleston, SC
Wayne Weart, Pharm.d, BCPS, FASHP
SC College of Pharm - MUSC Campus
Charleston, SC
Pharmacist Learning Objectives (ACPE UAN: 0171-0000-12-008-L01-P; 0.2 CEU)
1. Describe the pharmacist's role in immunizations.
2. Discuss updates to national immunization recommendations.
3. Evaluate recently published vaccine-efficacy studies.
4. Compare and contrast available influenza vaccine products.
5. Review proper vaccine administration technique.
1. Describe the pharmacist's role in immunizations.
2. Discuss updates to national immunization recommendations.
3. Evaluate recently published vaccine-efficacy studies.
4. Compare and contrast available influenza vaccine products.
5. Review proper vaccine administration technique.
Technician Learning Objectives (ACPE UAN: 0171-0000-12-008-L01-T; 0.2 CEU)
1. Describe the technician's role in immunizations.
2. Discuss updates to national immunization recommendations.
3. Describe briefly "vaccine efficacy".
4. List available influenza vaccine products.
5. Review proper vaccine storage and handling.
1. Describe the technician's role in immunizations.
2. Discuss updates to national immunization recommendations.
3. Describe briefly "vaccine efficacy".
4. List available influenza vaccine products.
5. Review proper vaccine storage and handling.
Break
10:00 AM - 12:30 PM
10:00 AM - 10:30 AM
What's New in the Management of Type 2 Diabetes Mellitus? Lots!
Wayne Weart, Pharmd, BCPS, FASHP
SC College of Pharmacy - MUSC Campus
Charleston, SC
Wayne Weart, Pharmd, BCPS, FASHP
SC College of Pharmacy - MUSC Campus
Charleston, SC
Pharmacist Learning Objectives (ACPE UAN: 0171-0000-12-011-L01-P; 0.2 CEU)
1. Describe the relationship between obesity and the risk of type 2 diabetes and the benefits of lifestyle modification (IE diet and exercise) in reducing the risk and helping to manage patients with Type 2 diabetes.
2. Describe the current 2012 ADA clinical practice guidelines for the diagnosis and management of diabetes mellitus.
3. Discuss the appropriate use of metformin, sulfonylureas, TZD's, GLP-1 agonists, DPP-4 inhibn deciding upon the compelling inducations for spedific antihypertensive agents in treating selected patients and where JNC-VIII is likely to go.
4. Recommend a specific treatment regimen for a patient with hypertension and concurrent conditions
5. Identify the common drug therapy problems encountered in patients with hypertension and possible solutions.
1. Describe the relationship between obesity and the risk of type 2 diabetes and the benefits of lifestyle modification (IE diet and exercise) in reducing the risk and helping to manage patients with Type 2 diabetes.
2. Describe the current 2012 ADA clinical practice guidelines for the diagnosis and management of diabetes mellitus.
3. Discuss the appropriate use of metformin, sulfonylureas, TZD's, GLP-1 agonists, DPP-4 inhibn deciding upon the compelling inducations for spedific antihypertensive agents in treating selected patients and where JNC-VIII is likely to go.
4. Recommend a specific treatment regimen for a patient with hypertension and concurrent conditions
5. Identify the common drug therapy problems encountered in patients with hypertension and possible solutions.
Technician Learning Objectives (ACPE UAN: 0171-0000-12-011-L01-T; 0.2 CEU)
1. List the benefits of lifestyle modification (IE diet and exercise) in patients with Type 2 diabetes.
2. Identify medications used in the mangement of patients with Type 2 diabetes mellitus.
3. Describe the benefits of treating both blood pressure and lipids in patients with Type 2 diabetes.
1. List the benefits of lifestyle modification (IE diet and exercise) in patients with Type 2 diabetes.
2. Identify medications used in the mangement of patients with Type 2 diabetes mellitus.
3. Describe the benefits of treating both blood pressure and lipids in patients with Type 2 diabetes.
Pharmacy Continuing Education Credit: The South Carolina Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Grievances regarding the education programs must be submitted in writing to the SCPhA ACPE Administrator immediately following the program. In order to receive credit, the activity must be fully attended and an online evaluation must be completed within three weeks of the activity. Please see cruise materials and www.scrx.org for complete information including cancellation policies.
Immunization Update: 2012
Patricia H. Powell, Pharm. D, BCPS
Clinical Assistant Professor
South Carolina College of Pharmacy - USC Campus
Columbia, SC
Patricia H. Powell, Pharm. D, BCPS
Clinical Assistant Professor
South Carolina College of Pharmacy - USC Campus
Columbia, SC
8:00 AM - 10:00 AM
Monday, September 17, 2012
SCPhA Cruise on the Carnival Fantasy
Continuing Education Agenda
Sunday, September 16, 2012
Pharmacist Learning Objectives (ACPE UAN: 0171-0000-12-009-L01-P; 0.2 CEU)
1. Review the epidemiology and pathophysiology of heartburn.
2. Distinguish between GI disorders based upon patient symptoms.
3. Explain the nonpharmacologic treatment options for heartburn.
4. Compare and contrast current treatment options for frequent heartburn.
5. Evaluate the safety of long-term maintenance treatment for frequent heartburn.
1. Review the epidemiology and pathophysiology of heartburn.
2. Distinguish between GI disorders based upon patient symptoms.
3. Explain the nonpharmacologic treatment options for heartburn.
4. Compare and contrast current treatment options for frequent heartburn.
5. Evaluate the safety of long-term maintenance treatment for frequent heartburn.
Technician Learning Objectives (ACPE UAN: 0171-0000-12-009-L01-T; 0.2 CEU)
1. Review the epidemiology and pathophysiology of heartburn.
2. List the common symptoms of GI disorders.
3. List the nonpharmacologic treatment options for heartburn.
4. Discuss side effects of medications used for frequent heartburn.
1. Review the epidemiology and pathophysiology of heartburn.
2. List the common symptoms of GI disorders.
3. List the nonpharmacologic treatment options for heartburn.
4. Discuss side effects of medications used for frequent heartburn.
10:00 AM - 10:30 AM
Break
10:00 AM - 12:30 PM
Management of Frequent Heartburn
Patricia H. Powell, Pharm. D, BCPS
Clinical Assistant Professor
South Carolina College of Pharmacy - USC Campus
Columbia, SC
Patricia H. Powell, Pharm. D, BCPS
Clinical Assistant Professor
South Carolina College of Pharmacy - USC Campus
Columbia, SC
Pharmacist Learning Objectives (ACPE UAN: 0171-0000-12-010-L01-P; 0.2 CEU)
1. Discuss the importance of systolic blood presure vs. diastolic blood pressure and the potential effect of bedtime dosing of antihypertensives on the risk of cardiovascular events and the benefits of blood pressure lowering.
2. Describe the current evidence-based strategies for the management of hypertension, including both nondrug and drug therapy options.
s for heartburn.
3. Describe the data that the JNC-VII and the newer UK-NICE guidelines committee members used in deciding upon the compelling inducations for spedific antihypertensive agents in treating selected patients and where JNC-VIII is likely to go.
4. Recommend a specific treatment regimen for a patient with hypertension and concurrent conditions
5. Identify the common drug therapy problems encountered in patients and possible solutions.
1. Discuss the importance of systolic blood presure vs. diastolic blood pressure and the potential effect of bedtime dosing of antihypertensives on the risk of cardiovascular events and the benefits of blood pressure lowering.
2. Describe the current evidence-based strategies for the management of hypertension, including both nondrug and drug therapy options.
s for heartburn.
3. Describe the data that the JNC-VII and the newer UK-NICE guidelines committee members used in deciding upon the compelling inducations for spedific antihypertensive agents in treating selected patients and where JNC-VIII is likely to go.
4. Recommend a specific treatment regimen for a patient with hypertension and concurrent conditions
5. Identify the common drug therapy problems encountered in patients and possible solutions.
Technician Learning Objectives (ACPE UAN: 0171-0000-12-010-L01-T; 0.2 CEU)
1. Describe the difference between systolic blood pressure and diastolic blood pressure.
2. Name several benefits of blood pressure lowering.
3. Identify nondrug and drug therapy options for the management of hypertension.
4. Identify the common drug therapy problems encountered patients with hypertension.
1. Describe the difference between systolic blood pressure and diastolic blood pressure.
2. Name several benefits of blood pressure lowering.
3. Identify nondrug and drug therapy options for the management of hypertension.
4. Identify the common drug therapy problems encountered patients with hypertension.